Kohei Takizawa, Hiroyuki Ono, Noriaki Hasuike, Atsuo Takashima, Keiko Minashi, Narikazu Boku, Ryoji Kushima, Hiroshi Katayama, Gakuto Ogawa, Haruhiko Fukuda, Junko Fujisaki, Ichiro Oda, Tomonori Yano, Shinichiro Hori, Hisashi Doyama, Kingo Hirasawa, Yoshinobu Yamamoto, Ryu Ishihara, Satoshi Tanabe, Yasumasa Niwa, Masahiro Nakagawa, Masanori Terashima, Manabu Muto the Gastrointestinal Endoscopy Group (GIESG) and the Stomach Cancer Study Group (SCSG) of Japan Clinical Oncology Group

A nonrandomized, single-arm confirmatory trial of expanded endoscopic submucosal dissection indication for undifferentiated early gastric cancer: Japan Clinical Oncology Group study (JCOG1009/1010)

Gastric Cancer. 2021 Mar;24(2):479-491.

Masashi Takeuchi, Chiyo K Imamura, Eisuke Booka, Hiroya Takeuchi, Takuro Mizukami, Takeshi Kawakami, Taro Funakoshi, Kazushige Wakuda, Yu Aoki, Yasuo Hamamoto, Minoru Kitago, Hirofumi Kawakubo, Narikazu Boku, Yusuke Tanigawara, Yuko Kitagawa.

Prospective evaluation and refinement of an S-1 dosage formula based on renal function for clinical application.

Cancer Sci. 2021 Feb;112(2):751-759.

Naito Y, Aburatani H, Amano T, Baba E, Furukawa T, Hayashida T, Hiyama E, Ikeda S, Kanai M, Kato M, Kinoshita I, Kiyota N, Kohno T, Kohsaka S, Komine K, Matsumura I, Miura Y, Nakamura Y, Natsume A, Nishio K, Oda K, Oda N, Okita N, Oseto K, Sunami K, Takahashi H, Takeda M, Tashiro S, Toyooka S, Ueno H, Yachida S, Yoshino T, Tsuchihara K; Japanese Society of Medical Oncology; Japan Society of Clinical Oncology; Japanese Cancer Association.

Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1).

Int J Clin Oncol. 2021 Feb;26(2):233-283.

Naohiro Yoshida, Hisashi Doyama, Tomonori Yano, Takahiro Horimatsu, Noriya Uedo, Yoshinobu Yamamoto, Naomi Kakushima, Hiromitsu Kanzaki, Shinichiro Hori, Kenshi Yao, Ichiro Oda, Chikatoshi Katada, Chizu Yokoi, Ken Ohata, Kenichi Yoshimura, Hideki Ishikawa, Manabu Muto.

Early gastric cancer detection in high-risk patients: a multicentre randomised controlled trial on the effect of second-generation narrow band imaging.

Gut. 2021 Jan;70(1):67-75.

M Kawashima, M Murakami, T Saito, I Oyama, M Tauchi, K Oikawa, M Sekine, T Sekine, N Ozawa, Y.Saito, H Yamaji, Y Yagiuchi, A Kumagai and K Otani.

Lessons from and perspectives for healthcare student volunteer activities after the Fukushima disaster.

Radioprotection 2020, 55(4), 271–276.

Mitani Y, Kanai M, Kou T, Kataoka S, Doi K, Matsubara J, Ohashi S, Matsumoto S, Muto M.

Cancer of unknown primary with EGFR mutation successfully treated with targeted therapy directed by clinical next-generation sequencing: a case report.

BMC Cancer. 2020 Dec 2;20(1):1177.

Iwai T, Yoshimura M, Ashida R, Goto Y, Kishi T, Itasaka S, Shibuya K, Kanai M, Masui T, Fukuda A, Isoda H, Hiraoka M, Mizowaki T.

Hypofractionated intensity-modulated radiotherapy with concurrent chemotherapy for elderly patients with locally advanced pancreatic carcinoma.

Radiat Oncol. 2020 Nov 13;15(1):264.

Naomi Kakushima, Naohiro Yoshida, Hisashi Doyama, Tomonori Yano, Takahiro Horimatsu, Noriya Uedo, Yoshinobu Yamamoto, Hiromitsu Kanzaki, Shinichiro Hori, Kenshi Yao, Ichiro Oda, Satoshi Tanabe, Chizu Yokoi, Ken Ohata, Kenichi Yoshimura, Hideki Ishikawa & Manabu Muto.

Near-focus magnification and second-generation narrow-band imaging for early gastric cancer in a randomized trial

J Gastroenterol. 2020 Dec;55(12):1127-1137.

Okano N, Morizane C, Nomura S, Takahashi H, Tsumura H, Satake H, Mizuno N, Tsuji K, Shioji K, Asagi A, Yasui K, Kitagawa S, Kashiwada T, Ishiguro A, Kanai M, Ueno M, Ogura T, Shimizu S, Tobimatsu K, Motoya M, Nakashima K, Ikeda M, Okusaka T, Furuse J.

Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study).

Int J Clin Oncol. 2020 Oct;25(10):1835-1843.

Inagaki-Kawata Y, Yoshida K, Kawaguchi-Sakita N, Kawashima M, Nishimura T, Senda N, Shiozawa Y, Takeuchi Y, Inoue Y, Sato-Otsubo A, Fujii Y, Nannya Y, Suzuki E, Takada M, Tanaka H, Shiraishi Y, Chiba K, Kataoka Y, Torii M, Yoshibayashi H, Yamagami K, Okamura R, Moriguchi Y, Kato H, Tsuyuki S, Yamauchi A, Suwa H, Inamoto T, Miyano S, Ogawa S, Toi M.

Genetic and clinical landscape of breast cancers with germline BRCA1/2 variants.

Commun Biol. 2020 Oct 16;3(1):578.